Who are Nostopharma's investors?

Nostopharma's investors include Maryland TEDCO, TEDCO.

How much funding has Nostopharma raised?

Nostopharma has disclosed $500K raised across 2 rounds.

Where is Nostopharma headquartered?

Nostopharma is headquartered in Potomac, US.

Nostopharma

Potomac, US · Maryland LLC · 2 known investors

Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.

BiotechHealthtechMedical Devicesin /nostopharma

Founders & leadership

Ekaterina Vert-WongNamed on SEC filing

Jelena Gvozdenovic-JeremicNamed on SEC filing

Investors · 2

Maryland TEDCOUpper Marlboro · $500K – $1.5M

TEDCOColumbia

Reported raises · per SEC filings

Form D private placements

$500K disclosed across 2 rounds · 2023–2024

▶$250KraisedSep 2024 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Ekaterina Vert-WongExecutive Officer, Director
Jelena Gvozdenovic-JeremicExecutive Officer

Offering amount: $250K
Amount sold: $250K
First sale: Sep 2024
Incorporated: Limited Liability Company, Maryland
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$250KraisedJun 2023 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Ekaterina Vert-WongExecutive Officer, Director
Jelena JeremicExecutive Officer, Director

Offering amount: $250K
Amount sold: $250K
First sale: Jun 2023
Incorporated: Limited Liability Company, Maryland
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

TEDCO Invests in Nostopharma | citybizcitybiz.co · Jan 2025

Nostopharma Using LSN and RESI Navigate A Seed Roundblog.lifesciencenation.com · Jun 2020

NCC-PDI Announces Finalists in $250K Pediatric Pitch Competition - WFMJ.com News weather sports for Youngstown-Warren Ohiowfmj.com · Apr 2019

Frequently asked questions

What does Nostopharma do?: Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.
Who are Nostopharma's investors?: Nostopharma's investors include Maryland TEDCO, TEDCO.
How much funding has Nostopharma raised?: Nostopharma has disclosed $500K raised across 2 rounds.
Where is Nostopharma headquartered?: Nostopharma is headquartered in Potomac, US.